Association between reduced plasma 25-hydroxyvitamin D and increased risk of cancer in patients with inflammatory bowel disease

Affiliations

¹ Department of Gastroenterology, Alfred Hospital, Melbourne, Australia; Department of Gastroenterology, Monash University, Melbourne, Australia.
² Department of Gastroenterology, Monash University, Melbourne, Australia; Department of Gastroenterology and Hepatology, Eastern Health, Melbourne, Australia.

Comment

Matthew T Kitson et al. Clin Gastroenterol Hepatol. 2015 Apr.

. 2015 Apr;13(4):813-4.

doi: 10.1016/j.cgh.2014.04.031. Epub 2014 May 6.

¹ Department of Gastroenterology, Alfred Hospital, Melbourne, Australia; Department of Gastroenterology, Monash University, Melbourne, Australia.
² Department of Gastroenterology, Monash University, Melbourne, Australia; Department of Gastroenterology and Hepatology, Eastern Health, Melbourne, Australia.

No abstract available

Comment in

Reply: To PMID 24161349.
Ananthakrishnan AN. Ananthakrishnan AN. Clin Gastroenterol Hepatol. 2015 Apr;13(4):814. doi: 10.1016/j.cgh.2015.01.001. Epub 2015 Jan 7. Clin Gastroenterol Hepatol. 2015. PMID: 25576688 No abstract available.

Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases.
Ananthakrishnan AN, Cheng SC, Cai T, Cagan A, Gainer VS, Szolovits P, Shaw SY, Churchill S, Karlson EW, Murphy SN, Kohane I, Liao KP. Ananthakrishnan AN, et al. Clin Gastroenterol Hepatol. 2014 May;12(5):821-7. doi: 10.1016/j.cgh.2013.10.011. Epub 2013 Oct 23. Clin Gastroenterol Hepatol. 2014. PMID: 24161349 Free PMC article.